Akums Drugs & Pharma appoints Yuvraj Datta as President - Operational Strategy & Excellence

Written By :  Ruchika Sharma
Published On 2025-11-30 07:15 GMT   |   Update On 2025-11-30 07:15 GMT
Advertisement

New Delhi: Akums Drugs & Pharma has appointed Yuvraj Datta as its new President - Operational Strategy & Excellence.

Datta shared the update through a LinkedIn post, writing, "I’m happy to share that I’m starting a new position as President - Operational Strategy & Excellence at Akums Drugs & Pharmaceuticals Ltd!"
Alongside his new role at Akums, Datta also serves as a Board Advisor at 
Advertisement
BlueLotus Value Tradelink. His career spans positions at leading healthcare and pharmaceutical companies, including Zeon Lifesciences, GSK Pharma, and GSK Consumer Healthcare India.

Akums Drugs & Pharmaceuticals Ltd is a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services in India and overseas. The own the intellectual property for the manufacturing processes of several of its formulations, and its core business is focused on providing end-to-end product development and manufacturing solutions to clients. The company has presence in over 60 countries worldwide. Over 12% of all domestically used medications are produced by Akums in almost all therapeutic segments.

Read also: Akums Drugs & Pharma Hormonal manufacturing plant gets EAEU GMP Certification

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News